Open an account

QuidelOrtho

QDEL · NASDAQ

$14.21+$1.45 (+11.36%)TodayMarket closed ·
Prev close $12.76

About QDEL

QuidelOrtho Corp. operates as a vitro diagnostics company. The company is headquartered in San Diego, California and currently employs 6,500 full-time employees. The firm specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. The company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.

Employees
6,500
Headquarters
San Diego, California
Listed
Feb 1, 1991
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
quidelortho.com

QDEL key statistics

Market cap
875.02M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
2.06M
Volume
2.09M
Open price
$12.86
High today
$14.50
Low today
$12.82
52 Week high
$35.58
52 Week low
$9.92

QuidelOrtho (QDEL) at a glance

As of Oct 20, 2026, QuidelOrtho (QDEL) shares are priced at $14.21, giving the company a market cap of 875.02M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $12.82 and $14.50. The current price is 10.8% above the day's low and 2.0% below its high.

Volume so far is 2.09M shares, in line with the average of 2.06M shares a day.

Over the past year QuidelOrtho has ranged from $9.92 to $35.58, and now sits 17% of the way up that range.

QuidelOrtho met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $0.13 per share against an estimate of -$0.0474.

The average analyst price target is $16.32, 14.8% above the current price, from 4 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

0%of 4 analyst ratings say Buy
  • Buy0.0%
  • Hold75.0%
  • Sell25.0%
Price target · 5 analystsAvg $16.32
Low
$12.12
Now
$14.21
High
$21.00

QDEL earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 190.2% on average.

  1. Q3 FY24: reported $0.85 per share against an estimate of $0.3242
  2. Q4 FY24: reported $0.63 per share against an estimate of $0.6024
  3. Q1 FY25: reported $0.74 per share against an estimate of $0.5979
  4. Q2 FY25: reported $0.12 per share against an estimate of $0.0152
  5. Q3 FY25: reported $0.80 per share against an estimate of $0.4686
  6. Q4 FY25: reported $0.46 per share against an estimate of $0.4316
  7. Q1 FY26: reported -$0.04 per share against an estimate of $0.4029
  8. Q2 FY26: reported $0.13 per share against an estimate of -$0.0474

QDEL news

  • Press releasePRNewswire

    QuidelOrtho to Report Third Quarter 2026 Financial Results on November 3, 2026

  • Press releasePRNewswire

    QuidelOrtho Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

  • Press releasePRNewswire

    Did QuidelOrtho Corporation Insiders Breach their Fiduciary Duties to Shareholders?

  • Press releasePRNewswire

    QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor Relations

  • Press releasePRNewswire

    Early Intervention Aids Emergency Medicine Teams in Identifying and Personalizing Sepsis Treatment

  • Press releasePRNewswire

    Faster Answers, Better Decisions: ADLM 2026 Highlights

  • Avi Kapoor

    Nasdaq Gains Over 300 Points; US Employers Cut 23,000 Jobs In July

  • 12 Health Care Stocks Moving In Friday's Intraday Session

Similar companies

Companies in the same industry as QuidelOrtho

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.